Back to products

Aromasin 25 mg Tablet

Brand Name: Aromasin

Molecule: Exemestane

Strength: 25 mg

Quantity: 30 Tablets

Form: Tablet

Packaging Type: Strip

Manufacturer/Marketed By: Pfizer

Country of Origin: United States

Description

Aromasin 25mg Tablet contains Exemestane, a hormonal therapy used to treat hormone receptor–positive breast cancer in postmenopausal women. It lowers estrogen levels to help slow or stop cancer growth under oncologist supervision.

Benefits

Reduces estrogen-driven cancer growth
Lowers risk of breast cancer recurrence
Proven survival and disease-control benefits
Convenient once-daily oral therapy
Well-established hormonal treatment option

Indications and Usage

Aromasin 25mg Tablet is indicated for:

Hormone receptor–positive (HR+) breast cancer
Postmenopausal women
Adjuvant therapy following tamoxifen treatment
Advanced or metastatic breast cancer, if disease has progressed

Treatment must be prescribed and monitored by a cancer specialist.

How it Works

Exemestane blocks the aromatase enzyme, responsible for estrogen production in postmenopausal women. Lower estrogen levels deprive HR-positive cancer cells of the hormone they need to grow, helping slow or stop tumor progression.

Dosage & Administration

Usual dose: 25 mg once daily, or as prescribed
Take after a meal, at the same time each day
Swallow tablet whole with water
Do not skip or stop treatment without medical advice
Regular monitoring of bone density, liver function, and treatment response required

Side Effects

Common side effects:

Hot flashes
Fatigue
Joint or muscle pain
Headache
Sweating
Nausea

Serious side effects (seek medical care):

Severe bone thinning (osteoporosis)
Depression or mood changes
Liver problems
Severe allergic reactions

Warning and Precaution

Not recommended in pregnancy or breastfeeding
For postmenopausal women only, unless directed by oncologist
Use cautiously in patients with osteoporosis or vitamin D deficiency
Avoid alcohol and smoking to protect bone health
Inform doctor about ongoing medications, especially hormonal therapy
Report severe bone pain, jaundice, swelling, or breathing difficulty immediately